Methods of treatment of gastrointestinal inflammatory disease using Α4Β7 and TL1a binding proteins
TW202629595APending Publication Date: 2026-07-16SPYRE THERAPEUTICS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114139147
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-05-02
- Filing Date
- 2025-10-09
- Publication Date
- 2026-07-16
Abstract
Provided herein are methods of treating gastrointestinal inflammatory disease with half-life extended α4β7 and half-life extended TL1A binding antibodies.
Need to check novelty before this filing date? Find Prior Art